We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.53B
AUM Growth
+$13.3M
Cap. Flow
+$1.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
33.04%
Holding
332
New
36
Increased
68
Reduced
68
Closed
26

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$33.5M
2
LUV icon
Southwest Airlines
LUV
+$31.3M
3
MDT icon
Medtronic
MDT
+$20.3M
4
HSIC icon
Henry Schein
HSIC
+$15.5M
5
ISRG icon
Intuitive Surgical
ISRG
+$9.21M

Top Sells

Rank Stock Value
1
VMC icon
Vulcan Materials
VMC
+$37.6M
2
CHD icon
Church & Dwight Co
CHD
+$32.5M
3
NEE icon
NextEra Energy
NEE
+$32.4M
4
AGN
Allergan plc
AGN
+$21.9M
5
B
Barrick Mining
B
+$14.4M

Sector Composition

Rank Sector Weight
1 Industrials 21.18%
2 Communication Services 13.72%
3 Healthcare 11.57%
4 Materials 10.85%
5 Energy 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
B
26
Barrick Mining
B
$61.5B
$31.2M 2.03%
1,950,535
-905,349
-32% -$14.4M
NUE icon
27
Nucor
NUE
$60.5B
$31.1M 2.03%
523,314
+80,279
+18% +$4.49M
CB icon
28
Chubb
CB
$141B
$29.1M 1.9%
219,938
+12,427
+6% +$1.58M
PFE icon
29
Pfizer
PFE
$144B
$27.8M 1.81%
902,664
+384
+0% +$11.7K
MON
30
DELISTED
Monsanto Co
MON
$26.2M 1.71%
249,037
-11,459
-4% -$1.17M
F icon
31
Ford
F
$59.6B
$25M 1.63%
2,061,667
+126,482
+7% +$1.53M
BMY icon
32
Bristol-Myers Squibb
BMY
$130B
$24.2M 1.58%
413,877
-161,486
-28% -$8.83M
NFLX icon
33
Netflix
NFLX
$301B
$23.5M 1.53%
1,899,590
+2,820
+0.1% +$33.4K
PANW icon
34
Palo Alto Networks
PANW
$260B
$22.3M 1.46%
1,071,570
-28,134
-3% -$674K
MDT icon
35
Medtronic
MDT
$111B
$18.6M 1.22%
261,797
+258,842
+8,759% +$20.3M
HSIC icon
36
Henry Schein
HSIC
$9.76B
$15.3M 1%
+256,571
New +$15.5M
HES
37
DELISTED
Hess
HES
$11M 0.72%
176,730
+27,875
+19% +$1.52M
ISRG icon
38
Intuitive Surgical
ISRG
$130B
$9.14M 0.6%
129,708
+125,208
+2,782% +$9.21M
EW icon
39
Edwards Lifesciences
EW
$48.2B
$8.7M 0.57%
278,475
+255,855
+1,131% +$8.29M
IBM icon
40
IBM
IBM
$214B
$7.66M 0.5%
48,272
+35,983
+293% +$5.48M
DXCM icon
41
DexCom
DXCM
$28.9B
$6.03M 0.39%
403,732
+383,732
+1,919% +$6.8M
TT icon
42
Trane Technologies
TT
$104B
$5.6M 0.37%
+74,600
New +$5.38M
JNJ icon
43
Johnson & Johnson
JNJ
$643B
$3.91M 0.25%
33,906
+12,467
+58% +$1.44M
CBL
44
DELISTED
CBL& Associates Properties, Inc.
CBL
$3.27M 0.21%
284,500
-41,500
-13% -$481K
AZN icon
45
AstraZeneca
AZN
$267B
$3.1M 0.2%
56,775
-112,075
-66% -$6.36M
AXON
46
Axon Enterprise
AXON
$44.1B
$2.57M 0.17%
106,200
+96,200
+962% +$2.37M
BRK.A icon
47
Berkshire Hathaway Class A
BRK.A
$1.1T
$2.44M 0.16%
10
-2
-17% -$462K
MSI icon
48
Motorola Solutions
MSI
$73.1B
$2.15M 0.14%
+25,900
New +$2.03M
EXP icon
49
Eagle Materials
EXP
$6.86B
$2.12M 0.14%
+21,516
New +$1.93M
SBUX icon
50
Starbucks
SBUX
$118B
$1.87M 0.12%
+33,667
New +$1.87M
1
2
3 4 5

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q4 2016 Portfolio in Review

As of Q4 2016, R.H. Bluestein & Co held 332 positions worth $1.53B, up 0.87% from $1.52B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

R.H. Bluestein & Co's Q4 2016 filing shows 36 new, 68 increased, 68 reduced and 26 closed positions. Its largest new stake was Union Pacific: 340,837 shares worth $35.3M. The largest sale was Vulcan Materials, an estimated $37.6M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 15% a quarter earlier, followed by Communication Services and Healthcare.

  • R.H. Bluestein & Co's largest Q4 2016 buy was Union Pacific: 340,837 shares worth $35.3M.
  • R.H. Bluestein & Co added most to Medtronic in Q4 2016, an estimated $20.3M increase.
  • R.H. Bluestein & Co's biggest Q4 2016 reduction was Vulcan Materials, cutting an estimated $37.6M.
  • R.H. Bluestein & Co fully exited Treehouse Foods in Q4 2016, selling an estimated $9.47M.
  • R.H. Bluestein & Co's ten largest holdings make up 33% of its $1.53B portfolio in Q4 2016.
  • R.H. Bluestein & Co opened 36 new positions and closed 26 in Q4 2016.
  • R.H. Bluestein & Co's portfolio value rose 0.87% quarter-over-quarter to $1.53B.

Based on R.H. Bluestein & Co's 13F filing for Q4 2016, filed 13 Feb 2017.